Syncom Formulations Promoters Voluntarily Waive Final Dividend for FY26
Syncom Formulations' Promoters and Promoter Group voluntarily waived their entitlement to the final dividend for FY26. The proposed dividend was ₹0.10 per share. The waiver covers 47,53,47,599 shares, amounting to ₹4,75,34,759.90.
While the waiver is significant in absolute terms and demonstrates promoter commitment, it does not fundamentally alter the company's business operations or financial performance. The impact is primarily on dividend distribution.
The voluntary waiver of dividend by promoters is generally seen as a positive step, indicating a commitment to the company's financial health and potentially reinvesting in the business.
Syncom Formulations (India) Limited has announced that its Promoters and Promoter Group have voluntarily waived their entitlement to the final dividend proposed for the financial year ended March 31, 2026. The Board of Directors had recommended a final dividend of ₹0.10 per equity share of face value ₹1 each.
The company has 94,00,00,000 equity shares outstanding, with the Promoters and Promoter Group holding 47,53,47,599 of these shares. The total dividend amount proposed at ₹0.10 per share amounts to ₹9,40,00,000. However, the Promoters and Promoter Group have waived their portion of ₹4,75,34,759.90.
Consequently, the net final dividend, if declared by the shareholders at the upcoming Annual General Meeting, will be ₹4,64,65,240.10, payable on the remaining 46,46,52,401 equity shares. This waiver is unconditional and does not involve any consideration payable by the company to the shareholders.
What to do with a filing like this
Syncom Formulations (India) Limited filed this with the NSE as a statutory disclosure, categorised under dividend. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Syncom Formulations (India) Limited. Read the original for the full detail.